Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fibromed Inc.

Latest From Fibromed Inc.

Helix Therapeutics Inc.

Pharmaceuticals; anti-proliferative agents. Helix will pursue a three-pronged attack on fibrosis, blocking key enzymes responsible for cellular proliferation, formation of collagen and production of funtional tissue growth factor-b. The company initially plans to focus on fibrosis resulting from medical or surgical procedures.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Fibromed Inc.
  • Senior Management
  • George A Oram, Pres. & CEO
    Edward G Bernstine, PhD, Chmn. & CSO
  • Contact Info
  • Fibromed Inc.
    Phone: (617) 367-4565
    376 Commercial St.
    Boston, MA 02109